Skip to content

Role of Ayurvedic drugs in Pregnancy

Role of Bala beeja churna and Jeevanti churna in fetal and maternal wellbeing in second Trimester Garbhini paricharya â?? A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043070
Enrollment
30
Registered
2022-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O269- Pregnancy related conditions, unspecified

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All pregnant woman of 13-14th week of pregnancy aged 20-40 years

Exclusion criteria

Exclusion criteria: 1.Hemoglobin below 9gm/dl 2.Pregnancy with uterine malformations and 3.congenital defect of uterus. 4.Multiple pregnancy 4.Pregnancy with uterine fibroid and carcinoma. 6.Pregnancy with Cardiovascular diseases. Pregnancy with any severe systemic illness

Design outcomes

Primary

MeasureTime frame
Fetal wellbeing Fetal biometry with USG Maternal Wellbeing assessed with mid upper arm circumference, pregnancy weight gain, Blood Pressure, Fasting Blood Sugar Level Timepoint: 4 months

Secondary

MeasureTime frame
Reduction in the rate of minor maternal ailments and major disorders pregnancy induced hypertension and gestational hypertensionTimepoint: 4 months

Countries

India

Contacts

Public ContactDr Bihani Sanjyal

National Institute of Ayurveda, Jaipur

Pushpalathania@gmail.com9413206790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026